Your browser doesn't support javascript.
loading
Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians.
Mehta, Atul; Belmatoug, Nadia; Bembi, Bruno; Deegan, Patrick; Elstein, Deborah; Göker-Alpan, Özlem; Lukina, Elena; Mengel, Eugen; Nakamura, Kimitoshi; Pastores, Gregory M; Pérez-López, Jordi; Schwartz, Ida; Serratrice, Christine; Szer, Jeffrey; Zimran, Ari; Di Rocco, Maja; Panahloo, Zoya; Kuter, David J; Hughes, Derralynn.
Afiliação
  • Mehta A; Lysosomal Storage Disorders Unit, Department of Haematology, Royal Free Hospital, UCL Medical School, London, UK. Electronic address: atul.mehta1@nhs.net.
  • Belmatoug N; Referral Centre for Lysosomal Diseases, University Hospital Paris Nord Val de Seine, Clichy, France. Electronic address: nadia.belmatoug@bjn.aphp.fr.
  • Bembi B; Academic Medical Centre Hospital of Udine, Regional Coordinator Centre for Rare Diseases, Udine, Italy. Electronic address: bembi.bruno@aoud.sanita.fvg.it.
  • Deegan P; Addenbrooke's Hospital, Cambridge, UK. Electronic address: patrick.deegan@addenbrookes.nhs.uk.
  • Elstein D; Shire, Zug, Switzerland. Electronic address: delstein-c@shire.com.
  • Göker-Alpan Ö; Lysosomal Disorders Unit and Center for Clinical Trials, O&O Alpan, LLC, Fairfax, VA, USA. Electronic address: zalpan@aol.com.
  • Lukina E; National Research Center for Hematology, Moscow, Russia. Electronic address: elenalukina02@gmail.com.
  • Mengel E; Villa Metabolica, Center for Pediatric and Adolescent Medicine, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany. Electronic address: Karl-Eugen.Mengel@unimedizin-mainz.de.
  • Nakamura K; Kumamoto University Hospital, Kumamoto, Japan. Electronic address: nakamura@kumamoto-u.ac.jp.
  • Pastores GM; University College Dublin, and Mater Misericordiae University Hospital, Dublin, Ireland. Electronic address: gpastores@mater.ie.
  • Pérez-López J; Unit of Rare Diseases, Hospital Vall d'Hebron, Barcelona, Spain. Electronic address: jordperez@vhebron.net.
  • Schwartz I; Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil; Department of Genetics, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil. Electronic address: idadschwartz@gmail.com.
  • Serratrice C; Foundation Hospital Saint Joseph, Marseille, France and Geneva University Hospital, Thonex, Switzerland. Electronic address: cserratrice@hopital-saint-joseph.fr.
  • Szer J; Royal Melbourne Hospital, Parkville, Victoria, Australia. Electronic address: Jeff.Szer@mh.org.au.
  • Zimran A; Gaucher Clinic, Shaare Zedek Medical Center, affiliated with the Hebrew University-Hadassah Medical School, Jerusalem, Israel. Electronic address: azimran@gmail.com.
  • Di Rocco M; Unit of Rare Diseases, Department of Pediatrics, Giannina Gaslini Institute, Genoa, Italy. Electronic address: Majadirocco@gaslini.org.
  • Panahloo Z; Shire, Zug, Switzerland. Electronic address: zpanahloo@shire.com.
  • Kuter DJ; Center for Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. Electronic address: DKUTER@mgh.harvard.edu.
  • Hughes D; Lysosomal Storage Disorders Unit, Department of Haematology, Royal Free Hospital, UCL Medical School, London, UK. Electronic address: rmgvdah@ucl.ac.uk.
Mol Genet Metab ; 122(3): 122-129, 2017 11.
Article em En | MEDLINE | ID: mdl-28847676
ABSTRACT
Gaucher disease (GD) is a rare hereditary disorder caused by a deficiency of the lysosomal enzyme ß-glucocerebrosidase. Diagnosis is challenging owing to a wide variability in clinical manifestations and severity of symptoms. Many patients may experience marked delays in obtaining a definitive diagnosis. The two surveys reported herein aimed to explore the patient journey to diagnosis of GD from the perspectives of Gaucher expert physicians and patients. Findings from the surveys revealed that many patients experienced diagnostic delays and misdiagnoses, with nearly 1 in 6 patients stating that they were not diagnosed with GD for 7years or more after first consulting a doctor. Physicians and patients both reported multiple referrals to different specialties before a diagnosis of GD was obtained, with primary care, haematology/haematology-oncology and paediatrics the main specialties to which patients first presented. Splenomegaly, thrombocytopenia, anaemia and bone pain were reported as the most common medical problems at first presentation in both surveys. These findings support a clear need for straightforward and easy-to-follow guidance designed to assist non-specialists to identify earlier patients who are at risk of GD.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pacientes / Médicos / Doença de Gaucher Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Child / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pacientes / Médicos / Doença de Gaucher Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Child / Humans / Male Idioma: En Ano de publicação: 2017 Tipo de documento: Article